Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Bdigginson Mar 15, 2018 10:24am
123 Views
Post# 27719550

RE:RE:RE:RE:RE:Too bad

RE:RE:RE:RE:RE:Too badEasy , they vote ! 
But I think they’ll get the approval too bad the shelf is at our doorsteps ,, once they burn through the rest of the line , which based on the burn should be around July end they’ll have to start flooding shares, which should start after they burn 60 % or so of the line ... 40% drawn in 2.5 months .... yikes ..
what did they do with the 1.70 raise  money’s from last year.... I guess that’s gonzo!

anywhoo even with fda on the due date . They can’t get product to market and start to clear their receivables before their out of cash ....

expect 100 million on first issue that should dilute the sp by10%
crossing fingers that some haven’t done their DD and will buy into a bump on FDA approval ...
expect FDA first week in April .... 

sleezeball move would be to be to issue before .....


Bullboard Posts